The Prague Post - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.177035
AFN 81.881437
ALL 99.252011
AMD 444.591119
ANG 2.049629
AOA 1037.159008
ARS 1294.140507
AUD 1.780172
AWG 2.047025
AZN 1.859435
BAM 1.956825
BBD 2.294803
BDT 138.092365
BGN 1.957857
BHD 0.428625
BIF 3332.101328
BMD 1.137236
BND 1.492134
BOB 7.854392
BRL 6.60529
BSD 1.136596
BTN 97.022843
BWP 15.66621
BYN 3.71968
BYR 22289.824581
BZD 2.282996
CAD 1.574122
CDF 3271.828141
CHF 0.930816
CLF 0.028662
CLP 1099.888868
CNY 8.30179
CNH 8.290894
COP 4901.486936
CRC 571.199327
CUC 1.137236
CUP 30.136753
CVE 110.770869
CZK 25.063091
DJF 202.109957
DKK 7.466602
DOP 68.803308
DZD 150.7588
EGP 58.143348
ERN 17.058539
ETB 151.279275
FJD 2.597109
FKP 0.855951
GBP 0.857288
GEL 3.115894
GGP 0.855951
GHS 17.695207
GIP 0.855951
GMD 81.319015
GNF 9843.347287
GTQ 8.754588
GYD 238.429138
HKD 8.82913
HNL 29.46444
HRK 7.446167
HTG 148.317723
HUF 408.387158
IDR 19177.096068
ILS 4.192295
IMP 0.855951
INR 97.094362
IQD 1489.779092
IRR 47906.06434
ISK 145.099624
JEP 0.855951
JMD 179.644139
JOD 0.806641
JPY 161.924772
KES 147.274287
KGS 99.205076
KHR 4566.002554
KMF 492.999324
KPW 1023.51235
KRW 1613.044242
KWD 0.348711
KYD 0.947196
KZT 594.971784
LAK 24598.413793
LBP 101896.340747
LKR 339.937138
LRD 227.418773
LSL 21.444738
LTL 3.357962
LVL 0.687903
LYD 6.221303
MAD 10.547824
MDL 19.662304
MGA 5177.713287
MKD 61.514233
MMK 2387.450153
MNT 4055.721375
MOP 9.086962
MRU 44.847502
MUR 51.278108
MVR 17.514203
MWK 1974.241768
MXN 22.425622
MYR 5.012364
MZN 72.675052
NAD 21.444738
NGN 1824.922464
NIO 41.821916
NOK 11.909658
NPR 155.236349
NZD 1.90379
OMR 0.437833
PAB 1.136596
PEN 4.279398
PGK 4.700463
PHP 64.49549
PKR 319.107143
PLN 4.278742
PYG 9097.767521
QAR 4.140219
RON 4.97893
RSD 117.291464
RUB 93.451578
RWF 1609.188866
SAR 4.267179
SBD 9.516785
SCR 16.196165
SDG 682.883256
SEK 10.940516
SGD 1.490626
SHP 0.893689
SLE 25.900542
SLL 23847.250746
SOS 649.950735
SRD 42.248639
STD 23538.488054
SVC 9.945212
SYP 14786.177003
SZL 21.402605
THB 37.923371
TJS 12.206811
TMT 3.980326
TND 3.398079
TOP 2.663521
TRY 43.238621
TTD 7.712041
TWD 36.987449
TZS 3056.318533
UAH 47.101683
UGX 4166.329832
USD 1.137236
UYU 47.664978
UZS 14768.739292
VES 91.955341
VND 29420.293975
VUV 137.567375
WST 3.158108
XAF 656.312471
XAG 0.034749
XAU 0.000336
XCD 3.073437
XDR 0.816192
XOF 653.910715
XPF 119.331742
YER 278.907149
ZAR 21.404938
ZMK 10236.48952
ZMW 32.36396
ZWL 366.189511
  • CMSD

    0.0400

    21.96

    +0.18%

  • SCS

    0.0500

    9.76

    +0.51%

  • RIO

    1.0100

    58.17

    +1.74%

  • NGG

    0.6300

    72.11

    +0.87%

  • CMSC

    0.0400

    21.82

    +0.18%

  • GSK

    0.5600

    35.93

    +1.56%

  • BTI

    0.5400

    42.37

    +1.27%

  • AZN

    0.5400

    67.59

    +0.8%

  • BCE

    0.4200

    22.04

    +1.91%

  • BCC

    0.7800

    93.47

    +0.83%

  • BP

    0.6600

    28.32

    +2.33%

  • JRI

    0.1600

    12.4

    +1.29%

  • RYCEF

    -0.1400

    9.36

    -1.5%

  • RELX

    1.0000

    52.2

    +1.92%

  • VOD

    0.1350

    9.305

    +1.45%

  • RBGPF

    63.5900

    63.59

    +100%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

J.Simacek--TPP